Join

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

  • Marcus Corporation logo
    PR··Consumer Discretionary·
    D-BOX Technologies, Inc. to Launch Motion Seating in Multiple Auditoriums at Marcus Theatres Locations in Oakdale, Minn. and Orland Park, Ill.

    MONTREAL, July 24, 2026 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. ("D-BOX") (TSX:DBO) today announced the introduction of D-BOX premium haptic and motion seating in three auditoriums at Marcus Theatres’s® Oakdale Cinema in Oakdale, Minnesota, and in three auditoriums at Marcus Theatres’s Orland Park Cinema in Orland Park, Illinois. Marcus Theatres is the fourth largest theatre circuit in the United States and a division of Marcus Corporation (NYSE:MCS). "At Marcus Theatres, we are always looking for new ways to elevate the moviegoing experience and give our guests more ways to enjoy the biggest films," said Jeffry F. Tomachek, President of Marcus Theatres. "D-BOX’s motion seating offers

  • Sierra Bancorp logo
    PR··Finance·
    Sierra Bancorp Announces 4% Increase in Quarterly Cash Dividend

    Sierra Bancorp (NASDAQ:BSRR), parent of Bank of the Sierra, announced that its Board of Directors has declared a regular quarterly cash dividend of $0.27 per share. This represents an increase of $0.01 per share, or 4%, relative to the dividend paid last quarter. The dividend was approved subsequent to the Board’s review of the Company’s financial performance and capital for the quarter ended June 30, 2026, and will be paid on August 10, 2026, to shareholders of record as of August 3, 2026. Counting dividends paid by Bank of the Sierra prior to the formation of Sierra Bancorp, the Company has paid regular cash dividends to shareholders every year since 1987, comprised of annual dividends th

  • Arbe Robotics Ltd. logo
    PR··Technology·
    Arbe to Announce Second Quarter 2026 Financial Results and Hold a Conference Call on August 6, 2026

    TEL AVIV, Israel, July 24, 2026 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ:ARBE) (TASE: ARBE), a global leader in perception radar solutions, today announced that it will hold a conference call to discuss its second quarter 2026 financial results on Thursday, August 6, 2026 at 8:30 a.m. ET. The company will issue its financial results before the US market opens that same day. Conference Call and Webcast DetailsSpeakers will include Kobi Marenko, President, Ram Machness, Chief Executive Officer, and Karine Pinto-Flomenboim, Chief Financial Officer.The call will be webcast live and accessible from a link on Arbe's Investor Relations website at: https://ir.arberobotics.com. The call may also be

  • BorgWarner Inc. logo
    PR··Consumer Discretionary·
    BorgWarner Secures Motorcycle Dual-Clutch Transmission Program in China

    Integrated Dual-Clutch Transmission (DCT) system targets motorcycle and four-wheeled vehicle applications above 500 ccTechnology improves fuel economy and enhances the riding experienceBorgWarner upgrades from key component supplier to systems solution providerAUBURN HILLS, Mich., July 24, 2026 /PRNewswire/ -- BorgWarner has secured a new DCT program with a Chinese motorcycle customer, with start of production planned for the third quarter of 2027. Under the program, BorgWarner will provide a systems solution that includes dual clutches, hydraulic control modules and clutch control software for two-wheeled motorcycles and four-wheeled vehicles with engine displacement above 500 cc.          

  • KB Home logo
    PR··Consumer Discretionary·
    KB HOME OPENS TOWNSEND: NEW PAIRED HOMES FROM THE MID $700s IN SANTEE, CALIFORNIA

    New community in San Diego County within walking distance of local schools, parks and outdoor recreation is now open for tours.SANTEE, Calif., July 24, 2026 /PRNewswire/ -- KB Home (NYSE:KBH), one of the largest and most trusted homebuilders in the U.S., today announced the opening of Townsend, which offers a rare opportunity to own a new townhome in Santee, California.   Townsend at a Glance:Price: From the mid $700,000sLocation: Santee, California, at the corner of Mission Gorge Road and Aubrey Glen Drive near Highways 52 and 125Home type: Three-story paired homesBedrooms/baths: 3 bedrooms and 2.5 bathsSchool districts: Sante

  • Corteva Inc. logo
    PR··Consumer Staples·
    Corteva Declares Quarterly Dividend

    INDIANAPOLIS, July 24, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE:CTVA) today announced its Board of Directors has authorized a common stock dividend of $0.18 cents per share, payable September 15, 2026, to the Company's shareholders of record on September 1, 2026. EIDP, Inc. Announces Preferred Stock DividendThe Board of Directors of EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company) (EIDP) declared regular preferred stock dividends of $1.12-1/2 per share on the $4.50 series preferred stock and $0.87-1/2 per share on the $3.50 series preferred stock – both payable October 23, 2026, to EIDP stockholders of record

  • Lightspeed Commerce Inc. Subordinate Voting Shares logo
    PR··Technology·
    Lightspeed Commerce Integrates with Meta Conversions API to Help Retailers Measure In-Store Sales From Digital Ads

    MONTREAL, July 24, 2026 /CNW/ -- Lightspeed Commerce Inc. (NYSE:LSPD) (TSX:LSPD) ("Lightspeed" or the "Company"), the unified omnichannel platform powering ambitious retail, golf and hospitality businesses in over 100 countries, today announced the launch of Lightspeed with Meta Conversions API for Lightspeed Retail. The integration helps brick-and-mortar retailers better understand how Meta ads influence in-store purchases, making it easier to measure performance and optimize campaigns around revenue-driving outcomes. With Lightspeed with Meta Conversions API, retail merchants can connect their stores directly to Meta, automat

  • Agnico Eagle Mines Limited logo
    PR··Basic Materials·
    AGNICO EAGLE ANNOUNCES INVESTMENT IN CADILLAC MINES CORPORATION

    Stock Symbol: AEM (NYSE and TSX)TORONTO, July 24, 2026 /CNW/ -- Agnico Eagle Mines Limited (NYSE:AEM) (TSX:AEM) ("Agnico Eagle") announced today that it has entered into a subscription agreement dated July 23, 2026 (the "Subscription Agreement") with Cadillac Mines Corporation ("Cadillac"), pursuant to which Agnico Eagle agreed to acquire 8,696,000 common shares of Cadillac ("Common Shares") at a price of C$6.90 per Common Share for total consideration of C$60,002,400.00(the "Private Placement"). The Private Placement is subject to certain closing conditions, including the closing of Cadillac's initial public offering of Common Shares (the "IPO") pursuant to Cadillac's final long form base P

  • Liberty Global Ltd. logo
    Liberty Global Ltd. logo
    PR··Telecommunications·
    Liberty Global Reports Q2 2026 Results

    DENVER, July 24, 2026 (GLOBE NEWSWIRE) -- Liberty Global Ltd. announces its Q2 2026 financial results. CEO Mike Fries stated, "In the second quarter, we continued to execute against our strategic priorities including taking key steps towards unlocking value for shareholders through the planned Ziggo Group spin-off as early as mid-2027: Liberty Telecom: Our Telecom operations continued to focus on driving commercial momentum and investing in the future-proofing of our infrastructure. In the Benelux, VodafoneZiggo delivered positive broadband net adds with the best quarterly performance in six years driven by continued execution of the How We Win plan, while Telenet delivered the f

  • Lamb Weston Holdings Inc. logo
    PR··Consumer Staples·
    Lamb Weston Announces Q4 and Full Year Fiscal 2026 Results; Company Delivered Net Sales and Adjusted EBITDA Exceeding High End of Guidance and Advanced Focus to Win Strategy

    Strong North America performance more than offsets International challenges Net Sales for the full-year fiscal 2026 increased 2% year-over-year to $6,612 million and exceeded the high end of the Company’s guidance, which was $6,550 million Net Income and Adjusted Net Income(1) for the full-year fiscal 2026 were $290 million and $420 million Reported and Adjusted Diluted EPS(1) for the full-year fiscal 2026 were $2.08 and $3.01 Adjusted EBITDA(1) for the full-year fiscal 2026 was $1,147 million and exceeded the high end of the Company’s guidance, which was $1,140 million Lamb Weston Holdings, Inc. (NYSE:LW) announced today its fiscal fourth quarter and full year 2026 results a

  • First Hawaiian Inc. logo
    PR··Finance·
    First Hawaiian, Inc. Reports Second Quarter 2026 Financial Results and Declares Dividend

    HONOLULU, July 24, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ:FHB), ("First Hawaiian" or the "Company") today reported financial results for its quarter ended June 30, 2026. "The second quarter was another strong quarter, reflecting the strength of our business model, the disciplined execution by our team and the trust our customers place in us," said Bob Harrison, Chairman, President and Chief Executive Officer. "The announced acquisition of Tri Counties Bank builds on that momentum, bringing together two strong banks with shared values and complementary strengths to better serve our customers and communities while creating long-term value for our shareholders." On July 22, 2

  • OptimumBank Holdings Inc. logo
    PR··Finance·
    OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2026

    Fort Lauderdale, FL, July 24, 2026 (GLOBE NEWSWIRE) -- OptimumBank Holdings, Inc. (NYSE:OPHC) (the "Company") is a financial holding company and owns 100% of OptimumBank (the "Bank"), a Florida-chartered commercial bank, OptimumHUD Loans, LLC (d/b/a as OptimumFunding, LLC), a wholly owned non-bank Bridge and HUD-lender and OptimumFinance, LLC, a non-bank, wholly owned financing subsidiary. The Company is pleased to announce net income of $6.7 million, or $0.40 per basic share, and $0.28 per diluted share, for the second quarter of 2026, compared to $4.7 million, or $0.39 per basic share, and $0.20 per diluted share in the first quarter of 2026 and $3.6 million, or $0.31 per basic share, an

  • Estrella Immunopharma Inc. logo
    PR··Health Care·
    Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and Reports Durable Response Rate in Advanced B-Cell Non-Hodgkin’s Lymphoma

    Estrella Immunopharma, Inc. (NASDAQ:ESLA) ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced that the first patient has been successfully dosed in the dose-expansion phase of its ongoing STARLIGHT-1 Phase I/II clinical trial evaluating EB103, a CD19-redirected ARTEMIS® T-cell therapy, in patients with relapsed/refractory (R/R) B-cell non-Hodgkin’s lymphoma (NHL). Estrella’s dosing of the first patient in the dose-expansion cohort follows encouraging efficacy data from the dose-escalation cohort. At the 6-month assessment of evaluable Phase I patients

  • DigitalOcean Holdings Inc. logo
    PR··Technology·
    DigitalOcean Reduces Leverage with No Effective Dilution and Minimal Cash Usage, Creating Additional Capacity to Fuel Growth

    Announces Closing of Repurchase of ~$472 Million Aggregate Principal Amount of its 0.00% Convertible Senior Notes Due 2030 and the Concurrent Registered Direct Offering of Common Stock Creates Capacity to Support Data Center and Compute Expansion amid Accelerating AI Native Customer Demand DigitalOcean Holdings, Inc. (NYSE:DOCN), the AI-Native Cloud, purpose-built for inference and agentic workloads, today announced the closing of a private repurchase (the "Repurchase") of approximately $472 million of its 0.00% convertible senior notes due 2030 (the "2030 Convertible Notes") and a registered direct offering of shares of common stock to holders of 2030 Convertible Notes participating in

  • Infinity Natural Resources Inc. logo
    PR··Energy·
    Infinity Natural Resources Announces Second Quarter 2026 Results Earnings Release and Conference Call Dates

    Infinity Natural Resources, Inc. ("Infinity" or the "Company") (NYSE:INR) announced today that it will report second quarter 2026 financial and operating results after the market close on Monday, August 10, 2026. Management will host a conference call the following day, Tuesday, August 11, 2026, at 10:00 a.m. ET to discuss the results. To participate in the call, register at https://events.q4inc.com/attendee/627523741 or dial +1 585 542 9983 (U.S. Local) or +1 833 461 5787 (U.S. Toll-Free), using Meeting ID: 627523741. A unique dial-in code will be provided upon registration via link. The conference call will also be webcast live on the Company’s investor relations website at https://ir.i

  • Organon & Co. logo
    PR··Health Care·
    New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults1

    The presentation at the 2026 Society for Pediatric Dermatology (SPD) Annual Meeting marked the first time pooled Phase 3 data from the ADORING 1 and 2 trials on Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD®) and ≥75% improvement in Eczema Area and Severity Index (EASI75) over time has been broken out into pediatric and adult age subsets1 VTAMA demonstrated consistent improvements in skin clearance and disease severity, as measured by the vIGA-AD and EASI1 Across pediatric age groups, therapeutic responses in patients with moderate to severe atopic dermatitis emerged as early as week 2 and continued through the end of the 8-week treatment period1 Organon

  • Gentex Corporation logo
    PR··Consumer Discretionary·
    Gentex Reports Second Quarter 2026 Financial Results

    ZEELAND, Mich., July 24, 2026 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ:GNTX), a leading supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics, today reported financial results for the three and six months ended June 30, 2026.Second Quarter 2026 Highlights Net sales of $651.3 millionGross margin of 37.0%, an increase of 280 basis points from second quarter 2025 and 320 basis points from first quarter 2026.Income from operations (GAAP) $141.3 million; adjusted income from operations (non-GAAP) $141.7 millionNet income attributable to Gentex (GAAP) $114.7 million; adjusted net income (non‑GAAP) $122.9 millionE

  • NIP Group Inc. logo
    PR··Consumer Discretionary·
    NIP Group Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

    ABU DHABI, United Arab Emirates, July 24, 2026 (GLOBE NEWSWIRE) -- NIP Group Inc. ("NIPG" or the "Company") (NASDAQ:NIPG) today announced that on July 21, 2026, it has received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), stating that the Company has regained compliance with Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement"). The matter is now closed. As previously disclosed, on March 24, 2026, the Company received a notification letter from Nasdaq, indicating that for the 32 consecutive business days prior to that date, the closing bid price of the Company’s American depositary shares (the "ADSs") had been

  • Silicon Motion Technology Corporation logo
    PR··Technology·
    Silicon Motion Confirms Quarterly Dividend

    TAIPEI, Taiwan and MILPITAS, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NASDAQ:SIMO) ("Silicon Motion" or the "Company"), a global leader in designing and marketing NAND flash controllers for solid state storage devices, confirms today its quarterly cash dividend. On October 27, 2025, the Board of Directors of the Company declared payment of an annual dividend of US$2.00 per ADS1, equivalent to US$0.50 per ordinary share, which will be paid in four quarterly installments of $0.50 per ADS, equivalent to US$0.125 per ordinary share. According to the previously announced record and payment dates, the next quarterly installment will be paid on August 20,

  • Immutep Limited logo
    PR··Health Care·
    Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

    SYDNEY, AUSTRALIA, July 24, 2026 (GLOBE NEWSWIRE) -- Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep" or "the Company"), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announced that an abstract for the investigator-initiated EFTISARC-NEO Phase II trial evaluating its first-in-class MHC Class II agonist, eftilagimod alfa ("efti"), has been accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2026, taking place 23–27 October 2026 in Madrid, Spain. The abstract reports health-related quality of life (HRQoL) data from EFTISARC-NEO. Details of the accepted abstract and poster are as follows: TitleHealth-related quality o